• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Catalog Number SCF10X25AGEN
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Capsular Contracture (1761); Erythema (1840); Fever (1858); Inflammation (1932); Local Reaction (2035); Seroma (2069)
Event Date 12/10/2014
Event Type  Injury  
Event Description
Healthcare professional reported implantation of seri and concomitant non-allergan breast implant and non-allergan alloderm brand surgical scaffold on (b)(6) 2014 for tissue support during right side breast reconstruction surgery.Post-implantation, on (b)(6) 2014, patient presented with redness and "little red bumps".Treatment included keflex, cipro, bactrim, and intravenous vancomycin.The device remains implanted and is unavailable for return.
 
Manufacturer Narrative
Further information regarding event and product details has been requested.No additional information is available at this time.The events of "redness" and "little red bumps" are physiological complications, and analysis of the device generally does not assist allergan in determining the probable cause of these events.These events are being reported because medical intervention was required, although device-relatedness has not been established.
 
Event Description
Healthcare professional reported additionally that the patient developed a fever immediately post-implantation.The device was removed and discarded on (b)(6) 2015.Upon removal, the healthcare professional noted a seroma in the breast pocket.The healthcare professional concluded that the device had been physiologically rejected.
 
Manufacturer Narrative
The patient term codes for fever and seroma are submitted in addition to the previously reported patient codes, not in replacement.The physician discarded the device when it was explanted, and it is no longer available for return.Therefore, allergan will not receive the device and no analysis or testing will be done.These events are being reported because medical intervention was required, although device-relatedness has not been established.
 
Manufacturer Narrative
The patient term code for inflammation is submitted in addition to the previously reported patient codes, not in replacement.These events are being reported because medical intervention was required, although device-relatedness has not been established.
 
Event Description
Healthcare professional reported additional information indicating the patient requires additional surgery to correct capsular contracture associated with her new breast implants, and residual inflammation that has been attributed to the seri device by the physician.
 
Manufacturer Narrative
The events of pain and capsular contracture are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.
 
Event Description
Patient reported that seri surgical scaffold was placed bilaterally ¿under the base of each implant and base of [patient] chest wall¿ on (b)(6) 2014.After ¿a couple weeks,¿ the patient experienced ¿low-grade fevers¿ and ¿blotchy redness on the skin of [patient] right breast.¿ over the following two months, patient noted continuation of ¿low-grade fevers¿ as well as ¿marked changes in the appearance of both [patient] breasts¿ and ¿pain¿.Mammography showed ¿fluid buildup along the inferior aspect of both breast implants.¿ on (b)(6) 2015, the patient underwent bilateral explant of both breast implants and the concomitantly placed seri surgical scaffold.Explant was attributed to ¿severe inflammatory response¿ and ¿failure of the seri surgical scaffold resulting in bilateral capsular contracture.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERI SURGICAL SCAFFOLD (US)
Type of Device
MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer (Section G)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key4395875
MDR Text Key5433023
Report Number3008374097-2014-00145
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/23/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2016
Device Catalogue NumberSCF10X25AGEN
Device Lot NumberP13091001A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/10/2014
Initial Date FDA Received01/06/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/30/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
IMPLANT AND SURGICAL SCAFFOLD.; PATIENT RECEIVED CONCOMITANT NON-ALLERGAN BREAST ; IMPLANT AND SURGICAL SCAFFOLD.; PATIENT RECEIVED CONCOMITANT NON-ALLERGAN BREAST
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexFemale
-
-